Toxys

Leiden, Netherlands Founded: 2014 • Age: 12 yrs
In vitro genotoxicity testing services are provided using proprietary technology.
Request Access

About Toxys

Toxys is a company based in Leiden (Netherlands) founded in 2014.. Toxys has raised $2.26 million across 2 funding rounds from investors including Rabobank, InnovationQuarter and KIKK Capital. Toxys offers products and services including ToxTracker, ReproTracker, and ToxProfiler. Toxys operates in a competitive market with competitors including Altis Biosystems, ATANIS Biotech, Inovotion, BioTalentum and Foresee Biosystems, among others.

  • Headquarter Leiden, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.26 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.26 M (USD), Series A

    Mar 16, 2020

  • Investors
    Rabobank

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Toxys

Toxys offers a comprehensive portfolio of products and services, including ToxTracker, ReproTracker, and ToxProfiler. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Discriminates DNA damage and oxidative stress mechanisms for toxicity assessment.

hiPSC-based test for early embryonic development and teratogen identification.

Mechanistic tool for understanding non-genotoxic carcinogen pathways.

People of Toxys
Headcount 10-50
Employee Profiles 12
Board Members and Advisors 4
Employee Profiles
People
Sabine Hartvelt
Study Director
People
Nynke Moelijker
Associate Scientist
People
Marlon Dijkshoorn
CFO
People
Marianne Brummelkamp
Office Manager

Unlock access to complete

Board Members and Advisors
people
Johan Sebregts
Director
people
Chris Newton
Director
people
Susan Swarte
Director
people
Joost Holthuis
Chair

Unlock access to complete

Funding Insights of Toxys

Toxys has successfully raised a total of $2.26M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.26 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $2.3M
  • First Round
  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2020 Amount Series A - Toxys Valuation KIKK Capital , Rabobank
Feb, 2016 Amount Series A - Toxys Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Toxys

Toxys has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Rabobank, InnovationQuarter and KIKK Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
KIKK Capital is engaged in investing in Dutch start-ups.
Founded Year Domain Location
Sector-agnostic VC firm investing primarily in the Netherlands
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Toxys

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Toxys

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Toxys Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Toxys

Toxys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, ATANIS Biotech, Inovotion, BioTalentum and Foresee Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of invitro platform for drug testing
domain founded_year HQ Location
Developer of a cell-based assay for the diagnosis of allergies
domain founded_year HQ Location
Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development
domain founded_year HQ Location
Human stem-cell technologies for drug testing and toxicology are provided.
domain founded_year HQ Location
Developer of in vitro assays for detection of potential toxicity in drug discovery
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Toxys

Frequently Asked Questions about Toxys

When was Toxys founded?

Toxys was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Toxys located?

Toxys is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.

Is Toxys a funded company?

Toxys is a funded company, having raised a total of $2.26M across 2 funding rounds to date.

What does Toxys do?

Toxys was founded in 2014 in Leiden, Netherlands, and operates in the biotechnology sector focused on safety testing. In vitro genotoxicity assessments are conducted through the ToxTracker method, which evaluates carcinogenicity and genotoxicity in mouse embryonic stem cells. Custom testing services are also available, along with the ToxPlot software for data analysis. Operations center on chemical and drug compound evaluations for regulatory compliance.

Who are the top competitors of Toxys?

Toxys's top competitors include Altis Biosystems, ABL Diagnostics and ATANIS Biotech.

What products or services does Toxys offer?

Toxys offers ToxTracker, ReproTracker, and ToxProfiler.

Who are Toxys's investors?

Toxys has 4 investors. Key investors include Rabobank, InnovationQuarter, KIKK Capital, and Zeeuws Investerings Fonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available